MedPath
NMPA Approval

Rivaroxaban Granules

国药准字H20243982

June 11, 2024

Drug Information

利伐沙班颗粒

颗粒剂

15mg

化学药品

June 11, 2024

Company Information

Applicant Company

浙江省金华市东阳市江北街道猴塘社区广福东街23号总部中心C幢西楼0802-1室

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.